Pharma-Bio Serv (PBSV) FCF Payout Ratio (2019 - 2026)
Pharma-Bio Serv's (PBSV) quarterly FCF Payout Ratio came in at 4.67 in Q2 2026, up 16.92% on a YoY basis from 4.0 in Q2 2025, and down 206.78% quarter-over-quarter from 4.38 in Q1 2026.
Powered by 
Analysis
Pharma-Bio Serv (PBSV) FCF Payout Ratio (2019 - 2026) Analysis & Trends
Pharma-Bio Serv (PBSV) has reported FCF Payout Ratio for 8 consecutive years, with 4.67 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, FCF Payout Ratio rose 16.92% year-over-year to 4.67; the trailing twelve-month figure through Jan 2026 stood at 0.01 (down 907.15% YoY), and the FY2025 full-year result was 7.76, down 227.48% from the prior year.
- FCF Payout Ratio slipped to 4.67 in Q2 2026 per PBSV's latest filing, from 4.38 in the prior quarter.
- Across five years, FCF Payout Ratio topped out at 4.38 in Q1 2026 and bottomed at 6.87 in Q2 2023.
- Historically, FCF Payout Ratio has averaged 1.99 across 5 years, with a median of 3.83 in 2022.
- The sharpest annual moves came in 2022 and 2025: FCF Payout Ratio slumped 164.21% in 2022, then soared 68.61% in 2025.
- Over 5 years, FCF Payout Ratio stood at 3.83 in 2022, then tumbled by 79.59% to 6.87 in 2023, then soared by 64.23% to 2.46 in 2024, then tumbled by 128.81% to 5.62 in 2025, then grew by 16.92% to 4.67 in 2026.
- According to Business Quant data, FCF Payout Ratio over the past three periods registered 4.67, 4.38, and 5.62 for Q2 2026, Q1 2026, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Accenture | 124.62 Bn | 115.58 Bn | 6.13 Bn | 0.28 |
| 2 | UL Solutions | 14.92 Bn | 14.51 Bn | 417.00 Mn | 0.32 |
| 3 | Gartner | 11.76 Bn | 10.28 Bn | 1.19 Bn | - |
| 4 | Tetra Tech | 9.19 Bn | 8.96 Bn | 243.21 Mn | 0.08 |
| 5 | Booz Allen Hamilton Holding | 8.76 Bn | 8.22 Bn | 1.46 Bn | 0.29 |
| 6 | Genpact | 6.27 Bn | 5.75 Bn | 490.34 Mn | 0.54 |
| 7 | Korn Ferry | 4.28 Bn | 3.15 Bn | 685.99 Mn | 0.10 |
| 8 | Fti Consulting | 4.20 Bn | 4.04 Bn | 316.27 Mn | - |
| 9 | Grand Canyon Education | 4.01 Bn | 3.73 Bn | 204.08 Mn | - |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | -4.67 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | -4.67 |
| Jan 31, 2026 | 4.38 |
| Apr 30, 2025 | -5.62 |
| Jan 31, 2025 | 4.00 |
| Apr 30, 2024 | -2.46 |
| Jan 31, 2024 | 2.38 |
| Apr 30, 2023 | -6.87 |
| Apr 30, 2022 | -3.83 |
| Jan 31, 2022 | -5.25 |
| Apr 30, 2021 | -1.45 |
| Jan 31, 2020 | 1.15 |
| Oct 31, 2019 | -3.14 |